Conference Coverage

Roux-en-Y improves NASH in obese patients

Publish date: December 2, 2015

 

AT THE LIVER MEETING 2015

References

sworcester@frontlinemedcom.com

Pages

Recommended Reading

High serum leptin, insulin levels linked to Barrett’s esophagus risk
MDedge Endocrinology
Cysteamine bitartrate provides no histologic improvement in children with NAFLD
MDedge Endocrinology
Novel botanical drug reduces hepatic fat content
MDedge Endocrinology
Reoperation risk doubled in Roux-en-Y over sleeve gastrectomy
MDedge Endocrinology
New ACOG recommendations encourage exercise during pregnancy
MDedge Endocrinology
Adolescents still struggling mentally years after bariatric surgery
MDedge Endocrinology
Overweight, obese patients at greater risk for knee replacement surgery
MDedge Endocrinology
Phone-based intervention helps drain sugary drinks from preschoolers’ diet
MDedge Endocrinology
Metformin did not improve glycemic control in type 1 diabetes
MDedge Endocrinology
Weight loss–induced drop in pancreatic triacylglycerol is specific to type 2 diabetes
MDedge Endocrinology